Evidence map›Paper›PMID 37079638›Full record

ArticlePloS one2023

Obscurin Rho GEF domains are phosphorylated by MST-family kinases but do not exhibit nucleotide exchange factor activity towards Rho GTPases in vitro.

Daniel Koch, Ay Lin Kho, Atsushi Fukuzawa, Alexander Alexandrovich, Kutti J Vanaanen, Andrew Beavil, Mark Pfuhl, Martin Rees, Mathias Gautel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. The varied functions of the giant muscle scaffold protein obscurin.Frontiers in cell and developmental biology · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Daniel KochRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.ORCID 0000-0002-4893-1774
Ay Lin KhoRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Atsushi FukuzawaRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Alexander AlexandrovichRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Kutti J VanaanenRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Andrew BeavilRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.ORCID 0000-0002-0768-122X
Mark PfuhlRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Martin ReesRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.ORCID 0000-0003-2361-5828
Mathias GautelRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
King's College London · GB

Funding

British Heart Foundation CH/08/001/25300British Heart Foundation FS/17/65/33481Medical Research Council MR/R003106/1Wellcome TrustWellcome Trust 201543/Z/16/Z
6 · The paper itself

Abstract

Obscurin is a giant muscle protein (>800 kDa) featuring multiple signalling domains, including an SH3-DH-PH domain triplet from the Trio-subfamily of guanosine nucleotide exchange factors (GEFs). While previous research suggests that these domains can activate the small GTPases RhoA and RhoQ in cells, in vitro characterization of these interactions using biophysical techniques has been hampered by the intrinsic instability of obscurin GEF domains. To study substrate specificity, mechanism and regulation of obscurin GEF function by individual domains, we successfully optimized recombinant production of obscurin GEF domains and found that MST-family kinases phosphorylate the obscurin DH domain at Thr5798. Despite extensive testing of multiple GEF domain fragments, we did not detect any nucleotide exchange activity in vitro against 9 representative small GTPases. Bioinformatic analyses show that obscurin differs from other Trio-subfamily GEFs in several important aspects. While further research is necessary to evaluate obscurin GEF activity in vivo, our results indicate that obscurin has atypical GEF domains that, if catalytically active at all, are subject to complex regulation.

Indexed as

Nucleotidesrho GTP-Binding ProteinsMuscle ProteinsRho Guanine Nucleotide Exchange FactorsSignal TransductionMuscle ProteinsNucleotidesrho GTP-Binding ProteinsRho Guanine Nucleotide Exchange Factors

Identifiers

PMID37079638
PMCPMC10118190
OpenAlexW4366463013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.